Britannia Life Sciences (XCNQ:BLAB) FCF Margin %: 166.08% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Britannia Life Sciences FCF Margin %?

Britannia Life Sciences XCNQ:BLAB FCF Margin % is 166.08% as of Mar. 2026. The stock has 5 warning signs investors should review. Among 960 Biotechnology companies, Britannia Life Sciences ranks worse than 63.85% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Britannia Life Sciences's Free Cash Flow for the three months ended in Mar. 2026 was C$-0.47 Mil. Britannia Life Sciences's Revenue for the three months ended in Mar. 2026 was C$-0.28 Mil. Therefore, Britannia Life Sciences's FCF Margin % for the quarter that ended in Mar. 2026 was 166.08%.

As of today, Britannia Life Sciences's current FCF Yield % is -10.04%.

The historical rank and industry rank for Britannia Life Sciences's FCF Margin % or its related term are showing as below:

XCNQ:BLAB' s FCF Margin % Range Over the Past 10 Years
Min: -710.03   Med: -7.59   Max: 339.46
Current: -243.58

During the past 6 years, the highest FCF Margin % of Britannia Life Sciences was 339.46%. The lowest was -710.03%. And the median was -7.59%.

XCNQ:BLAB's FCF Margin % is ranked worse than
63.85% of 960 companies
in the Biotechnology industry
Industry Median: -77.695 vs XCNQ:BLAB: -243.58

Britannia Life Sciences FCF Margin % Related Terms

Britannia Life Sciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Britannia Life Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Britannia Life Sciences FCF Margin % Chart

Britannia Life Sciences Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
FCF Margin %
Get a 7-Day Free Trial 37.15 26.01 339.46 -710.03 -243.37

Britannia Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,833.33 -676.47 -249.29 262.33 166.08

XCNQ:BLAB vs VRTX, REGN, MRNA: FCF Margin % Comparison

For the Biotechnology subindustry, Britannia Life Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Britannia Life Sciences FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Britannia Life Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Britannia Life Sciences's FCF Margin % falls into.


Britannia Life Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Britannia Life Sciences's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-1.156/0.475
=-243.37 %

Britannia Life Sciences's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.47/-0.283
=166.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 166.08% mean?
Britannia Life Sciences (XCNQ:BLAB) has a FCF Margin % of 166.08% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Britannia Life Sciences and its competitors. According to the industry distribution chart, Britannia Life Sciences ranks #613 out of 960 companies in the Biotechnology industry, placing it in the top 63.9%.
Is Britannia Life Sciences' FCF Margin % too high?
Britannia Life Sciences' current FCF Margin % is 166.08%. Based on the distribution chart, Britannia Life Sciences ranks #613 out of 960 companies in the Biotechnology industry, which is below the industry midpoint.
How does Britannia Life Sciences' FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Britannia Life Sciences ranks #613 out of 960 companies for FCF Margin %. This places Britannia Life Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Britannia Life Sciences and its competitors. Britannia Life Sciences's current FCF Margin % is 166.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Britannia Life Sciences stock overvalued right now?
Britannia Life Sciences (XCNQ:BLAB) has a current FCF Margin % of 166.08%. The current FCF Margin % is 166.08%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Britannia Life Sciences (XCNQ:BLAB), the current FCF Margin % is 166.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Britannia Life Sciences Business Description

Address 120 Adelaide Street West, Suite 2400, Toronto, ON, CAN, M5H 1T1
Britannia Life Sciences Inc provides product testing, safety assessment, and manufacturing services to the cosmetic and consumer packaged goods industries in the United Kingdom and globally.